Skip to main content

Advertisement

Table 4 Reports of resource utilization in non-bleeding patients with IMC

From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

Category Count %
Extended LOS 23 92.0%
Vit K 9 36.0%
FFP 8 32.0%
IVIG 5 20.0%
Plasmapheresis 5 20.0%
Steroids 4 16.0%
PLT 1 4.0%
Chemotherapy 0 0.0%
RBC 0 0.0%
  1. LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells
  2. Interventions among the 25 non-bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [35, 8, 9, 11, 12, 14, 15, 18, 21, 22, 2426, 2831, 35].